BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 17012694)

  • 1. Capacity of persons with mental retardation to consent to participate in randomized clinical trials.
    Fisher CB; Cea CD; Davidson PW; Fried AL
    Am J Psychiatry; 2006 Oct; 163(10):1813-20. PubMed ID: 17012694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Appreciation of research information in patients with bipolar disorder.
    Misra S; Socherman R; Hauser P; Ganzini L
    Bipolar Disord; 2008 Jul; 10(5):635-46. PubMed ID: 18657248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethical challenges in the conduct of research involving persons with mental retardation.
    Freedman RI
    Ment Retard; 2001 Apr; 39(2):130-41. PubMed ID: 11340962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Capacity to consent to research participation in adults with malignant glioma.
    Marson DC; Martin RC; Triebel KL; Nabors LB
    J Clin Oncol; 2010 Aug; 28(24):3844-50. PubMed ID: 20644102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the competence of persons with Alzheimer's disease in providing informed consent for participation in research.
    Kim SY; Caine ED; Currier GW; Leibovici A; Ryan JM
    Am J Psychiatry; 2001 May; 158(5):712-7. PubMed ID: 11329391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Informed consent and ethical reporting of research in clinical trials involving participants with psychotic disorders.
    Weissinger GM; Ulrich CM
    Contemp Clin Trials; 2019 Sep; 84():105795. PubMed ID: 31247285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Participation in dementia research: rates and correlates of capacity to give informed consent.
    Warner J; McCarney R; Griffin M; Hill K; Fisher P
    J Med Ethics; 2008 Mar; 34(3):167-70. PubMed ID: 18316457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health care decision-making by adults with mental retardation.
    Cea CD; Fisher CB
    Ment Retard; 2003 Apr; 41(2):78-87. PubMed ID: 12622524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new brief instrument for assessing decisional capacity for clinical research.
    Jeste DV; Palmer BW; Appelbaum PS; Golshan S; Glorioso D; Dunn LB; Kim K; Meeks T; Kraemer HC
    Arch Gen Psychiatry; 2007 Aug; 64(8):966-74. PubMed ID: 17679641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What do our patients understand about their trial participation? Assessing patients' understanding of their informed consent consultation about randomised clinical trials.
    Behrendt C; Gölz T; Roesler C; Bertz H; Wünsch A
    J Med Ethics; 2011 Feb; 37(2):74-80. PubMed ID: 21098797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--chapter 7: Informed consent and xenotransplantation clinical trials.
    Vanderpool HY
    Xenotransplantation; 2009; 16(4):255-62. PubMed ID: 19799766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inclusion of patients with severe mental illness in clinical trials: issues and recommendations surrounding informed consent.
    Welie SP; Berghmans RL
    CNS Drugs; 2006; 20(1):67-83. PubMed ID: 16396525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex between people with "mental retardation": an ethical evaluation.
    Spiecker B; Steutel J
    J Moral Educ; 2002 Jun; 31(2):155-69. PubMed ID: 15027439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired decision-making ability in subjects with Alzheimer's disease and willingness to participate in research.
    Kim SY; Cox C; Caine ED
    Am J Psychiatry; 2002 May; 159(5):797-802. PubMed ID: 11986134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of therapeutic misconception in older schizophrenia patients with a brief instrument.
    Dunn LB; Palmer BW; Keehan M; Jeste DV; Appelbaum PS
    Am J Psychiatry; 2006 Mar; 163(3):500-6. PubMed ID: 16513873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What do people at risk for Alzheimer disease think about surrogate consent for research?
    Kim SY; Kim HM; McCallum C; Tariot PN
    Neurology; 2005 Nov; 65(9):1395-401. PubMed ID: 16275826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. I don't like that, it's tricking people too much...: acute informed consent to participation in a trial of thrombolysis for stroke.
    Mangset M; Førde R; Nessa J; Berge E; Wyller TB
    J Med Ethics; 2008 Oct; 34(10):751-6. PubMed ID: 18827109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Informed consent as an ethical requirement in clinical trials: an old, but still unresolved issue. An observational study to evaluate patient's informed consent comprehension.
    Sanchini V; Reni M; Calori G; Riva E; Reichlin M
    J Med Ethics; 2014 Apr; 40(4):269-75. PubMed ID: 23728419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of Capacity to Consent to Research on Alzheimer's disease.
    Palmer BW; Harmell AL; Pinto LL; Dunn LB; Kim SY; Golshan S; Jeste DV
    Clin Gerontol; 2017; 40(1):24-34. PubMed ID: 28154452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Capacity to provide informed consent for participation in schizophrenia and HIV research.
    Moser DJ; Schultz SK; Arndt S; Benjamin ML; Fleming FW; Brems CS; Paulsen JS; Appelbaum PS; Andreasen NC
    Am J Psychiatry; 2002 Jul; 159(7):1201-7. PubMed ID: 12091200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.